Abuhay Habtamu Wagnew, Alemu Gebrie Getu, Aweke Mekuriaw Nibret, Alemu Tewodros Getaneh, Mengistu Berhanu, Mesfin Amare
Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Department of Human Nutrition, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
PLoS One. 2025 Apr 1;20(4):e0320730. doi: 10.1371/journal.pone.0320730. eCollection 2025.
Breast cancer is a global public health problem among reproductive-age women, with an estimated 670,000 deaths in 2022. It's also a pressing health challenge in Sub-Saharan African countries, driven by late-stage diagnoses and limited healthcare access, underscoring the urgent need for early screening and treatment initiatives to combat this growing epidemic. In Kenya, the burden was also significant, and multilevel factors such as individual, household, and community level factors that influence screening uptake are undermined. Furthermore, there were no nationally representative studies. Therefore, this study aimed to assess clinical breast cancer screening uptake (CBCSU) and associated factors among reproductive-age women: further analysis of Kenyan demographic and health survey (KDHS) 2022.
This study used a weighted nationally representative sample of 16,649 women from the 2022 KDHS. A Multilevel mixed effects binary logistic regression analysis was performed and in the multivariable analysis, variables with a p-value less than 0.05 were considered statistically significant. The strength of the association was evaluated using Adjusted Odds Ratios (AOR) along with their corresponding 95% confidence intervals (CI). STATA version 17 software was to for data management and statistical analysis.
The weighted prevalence of CBCSU in Kenya was 13.91% (95% CI: 13.33, 14.44). Besides, women aged 25 to 34 years (AOR = 1.86, 95% CI: 1.57, 2.21), and 35 to 49 years (AOR = 2.87, 95% CI: 2.40, 3.42) had higher odds of CBCSU. Women with primary education (AOR = 2.14, 95% CI: 1.56, 2.94) and those with secondary or higher education (AOR = 3.09, 95% CI: 2.23, 4.28) had higher odds of CBCSU. In addition, the odds of CBCSU were higher among women with a middle (AOR = 1.41, 95% CI: 1.19, 1.67) and a rich wealth index (AOR = 2.19, 95% CI: 1.84, 2.61). On the other hand, CBCSU was lower among non-contraceptive user women (AOR 0.78, 95% CI: 0.69, 0.87). Furthermore, women in communities with a high proportion of media exposure had higher CBCSU (AOR = 1.17, 95% CI: 1.04, 1.33).
In this study, the prevalence of CBCSU among reproductive-age women in Kenya was found to be low. Besides, factors such as age, educational status, wealth index, family planning utilization, and community media exposure were identified as significant contributors to screening uptake. Therefore, policymakers and stakeholders should design interventions that address factors contributing to low breast cancer screening uptake, particularly targeting women in areas with limited media exposure, to increase the uptake of clinical breast cancer screening.
乳腺癌是育龄女性面临的全球性公共卫生问题,2022年估计有67万人死亡。在撒哈拉以南非洲国家,这也是一项紧迫的健康挑战,原因是诊断延迟和医疗服务可及性有限,这凸显了开展早期筛查和治疗举措以应对这一日益严重的流行病的迫切需求。在肯尼亚,这一负担也很沉重,影响筛查接受度的个人、家庭和社区层面等多层面因素受到削弱。此外,此前没有全国代表性研究。因此,本研究旨在评估育龄女性的临床乳腺癌筛查接受度(CBCSU)及其相关因素:对2022年肯尼亚人口与健康调查(KDHS)的进一步分析。
本研究使用了来自2022年KDHS的16649名女性的加权全国代表性样本。进行了多层面混合效应二元逻辑回归分析,在多变量分析中,p值小于0.05的变量被视为具有统计学意义。使用调整后的优势比(AOR)及其相应的95%置信区间(CI)评估关联强度。使用STATA 17版软件进行数据管理和统计分析。
肯尼亚CBCSU的加权患病率为13.91%(95% CI:13.33,14.44)。此外,25至34岁的女性(AOR = 1.86,95% CI:1.57,2.21)以及35至49岁的女性(AOR = 2.87,95% CI:2.40,3.42)接受CBCSU筛查的几率更高。接受小学教育的女性(AOR = 2.14,95% CI:1.56,2.94)以及接受中学或更高教育的女性(AOR = 3.09,95% CI:2.23,4.28)接受CBCSU筛查的几率更高。此外,中等财富指数(AOR = 1.41,95% CI:1.19,1.67)和富裕财富指数(AOR = 2.19,95% CI:1.84,2.61)的女性接受CBCSU筛查的几率更高。另一方面,未使用避孕措施的女性接受CBCSU筛查的几率较低(AOR 0.78,95% CI:0.69,0.87)。此外,媒体曝光率高的社区中的女性接受CBCSU筛查的几率更高(AOR = 1.17,95% CI:1.04,1.33)。
在本研究中,发现肯尼亚育龄女性中CBCSU的患病率较低。此外,年龄、教育程度、财富指数、计划生育利用情况和社区媒体曝光等因素被确定为筛查接受度的重要影响因素。因此,政策制定者和利益相关者应设计干预措施,解决导致乳腺癌筛查接受度低的因素,特别是针对媒体曝光有限地区的女性,以提高临床乳腺癌筛查的接受度。